欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (4): 438-444.doi: 10.12092/j.issn.1009-2501.2023.04.011

• 综述与讲座 • 上一篇    下一篇

血小板内皮聚集受体1及其介导的信号通路在血小板和内皮细胞中的作用研究进展

李若柠1,郭展立1,王  媛1,孙建军2   

  1. 1内蒙古医科大学药学院,呼和浩特  010100,内蒙古;2内蒙古医科大学附属医院药学部,呼和浩特  010050,内蒙古

  • 收稿日期:2022-12-26 修回日期:2023-02-11 出版日期:2023-04-26 发布日期:2023-05-17
  • 通讯作者: 孙建军,男,博士,副主任药师,硕士研究生导师,研究方向:抗血栓药物治疗及机制研究。 E-mail:sunjianjun8840@bjmu.edu.cn
  • 作者简介:李若柠,女,硕士在读,研究方向:抗血栓药物治疗及机制研究。 E-mail:15594541706@163.com
  • 基金资助:
    国家自然科学基金地区项目(81960770);内蒙古自治区高等学校科学研究项目(NJZY22623)

Platelet-endothelial aggregation receptor 1 and its mediated signalling pathway Advances in the study of the role of platelets and endothelial cells

LI Ruoning1 , GUO Zhanli1, WANG Yuan1, SUN Jianjun2   

  1. 1School of Pharmacy, Inner Mongolia Medical University, Hohhot 010100, Inner Mongolia, China; 2Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, Inner Mongolia, China
  • Received:2022-12-26 Revised:2023-02-11 Online:2023-04-26 Published:2023-05-17

摘要: 血小板内皮聚集受体1(platelet endothelial aggregation receptor 1, PEAR1)是2005年被发现的一种跨膜受体,主要在血小板和内皮细胞上表达。PEAR1是血小板与血小板间相互接触的受体蛋白,在血小板活化和聚集过程中起着重要作用。内皮细胞在维持血管张力和血管修复方面发挥重要作用,PEAR1 通过影响其增殖和相关新生血管的形成,调控肿瘤的发生、发展过程。近年来,PEAR1逐渐被公认为是抗血栓药物的潜在靶点。本综述主要阐明血小板内皮聚集受体1在血小板和内皮细胞中的作用机制以及相关信号通路,为肿瘤相关血栓的药物治疗研究提供新思路。

关键词: 血小板内皮聚集受体1, 血小板, 内皮细胞, 信号通路, 肿瘤血栓药物

Abstract:

Platelet-aggregation  receptor 1 (PEAR1) is a transmembrane receptor identified in 2005 and expressed mainly on platelets and endothelial cells. PEAR1 is a receptor protein that contacts platelets with each other and plays an important role in platelet activation and aggregation. Endothelial cells play an important role in maintaining vascular tone and vascular repair, and PEAR1 regulates the process of tumourigenesis and development by affecting their proliferation and associated neovascularisation. In recent years, PEAR1 has gradually been recognized as a potential target for anti-thrombotic drugs. This review focuses on elucidating the mechanisms of platelet endothelial aggregation receptor 1 and related signaling pathways in platelets and endothelial cells, and provides new ideas for the study of drug therapy for tumour-associated thrombosis.

Key words: platelet endothelial aggregation receptor 1, platelets, endothelial cells, signaling pathways, tumor thrombotic drugs

中图分类号: